Français
ItalianoBond Merck Sharp & Dohme 5.85% ( US589331AQ02 ) in USD
| Issuer | Merck Sharp & Dohme | ||||||
| Market price |  100.00 % ⇌ |
||||||
| Country |  United States
|
||||||
| ISIN code |
 US589331AQ02 ( in USD )
|
||||||
| Interest rate | 5.85% per year ( payment 2 times a year) | ||||||
| Maturity | 30/06/2039 | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 750 000 000 USD | ||||||
| Cusip | 589331AQ0 | ||||||
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) | ||||||
| Moody's rating | Aa3 ( High grade - Investment-grade ) | ||||||
| Next Coupon | 30/12/2026 ( In 129 days ) | ||||||
| Detailed description |
A leading global biopharmaceutical company, known as MSD outside the United States and Canada. The Bond issued by Merck Sharp & Dohme ( United States ) , in USD, with the ISIN code US589331AQ02, pays a coupon of 5.85% per year. The coupons are paid 2 times per year and the Bond maturity is 30/06/2039 The Bond issued by Merck Sharp & Dohme ( United States ) , in USD, with the ISIN code US589331AQ02, was rated Aa3 ( High grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Merck Sharp & Dohme ( United States ) , in USD, with the ISIN code US589331AQ02, was rated A+ ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||